Original Articles: Atopic Dermatitis, Urticaria and Skin Disease
To add the references below to your reference management program: 1. Save the file; 2. Open your reference management program or EndNote; 3. Select File and Import |
82 Articles |
-
IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis
Maintz, L., Welchowski, T., Herrmann, N., et al. Allergy. First published: 17 January 2023
-
Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Kim, J., Kim, B.E., Berdyshev, E., et al. Allergy. First published: 07 January 2023
-
Autologous Th2-polarized lymphocytes induce atopic dermatitis lesions in non-atopic human skin xenotransplants
Keren, A., Reich, K., Bertolini, M., et al. Allergy. First published: 04 January 2023
-
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases
Aranda, C.J., Gonzalez-Kozlova, E., Saunders, S.P., et al. Allergy. First published: 29 November 2022
-
Anti-kit antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Terhorst-Molawi, D., Hawro, T., Grekowitz, E., et al. Allergy. First published: 16 November 2022
-
RAB25 coordinates filaggrin-containing keratohyalin granule maturation and affects atopic dermatitis severity
Jeong, H., Lee, N., Uhm, C., et al. Allergy. First published: 16 November 2022
-
Dysregulated lipidome of sebum in patients with atopic dermatitis
Yin, H., Qiu, Z., Zhu, R., et al. Allergy. First published: 29 October 2022
-
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
Renert-Yuval, Y., Pavel, A.B., Del Duca, E., et al. Allergy. First published: 22 October 2022
-
Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial
Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022
-
Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases
Walsemann, T., Böttger, M., Traidl, S., et al. Allergy. First published: 14 October 2022
-
Skin biomarkers predict development of atopic dermatitis in infancy
Rinnov, M.R., Halling, A.-S., Gerner, T., et al. Allergy. First published: 16 September 2022
-
Early initiation of short-term emollient use for the prevention of atopic dermatitis in high risk infants – the STOP AD randomised controlled trial
Chaoimh, C.N., Lad, D., Nico, C., et al. Allergy. First published: 23 August 2022
-
Molecular networks in atopic mothers impact the risk of infant atopy
Schedel, M., Leach, S.M., Strand, M.J., et al. Allergy. First published: 22 August 2022
-
Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis
Zhang, B., Roesner, L.M., Traidl, S., et al. Allergy. First published: 20 August 2022
-
The abundance of Ruminococcus bromii is associated with faecal butyrate levels and atopic dermatitis in infancy
Sasaki, M., Schwab, C., Ramirez Garcia, A., et al. Allergy. First published: 02 August 2022
-
Tonsillar transcriptional profiles in atopic and non-atopic subjects
Hanif, T., Ivaska, L.E., Ahmad, F., et al. Allergy. First published: 28 July 2022
-
Patient-centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis
Spekhorst, L.S., Bakker, D., Drylewicz, J., et al. Allergy. First published: 15 July 2022
-
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis
Berdyshev, E., Goleva, E., Bissonnette, R., et al. Allergy. First published: 11 July 2022
-
Development of the cold urticaria activity score
Ahsan, D. M., Altrichter, S., Gutsche, A., et al. Allergy. First published: 11 April 2022
-
Circadian rhythm affects the magnitude of contact hypersensitivity response in mice
Miyake, T., Egawa, G., Chow, Z., et al. Allergy. First published: 15 April 2022
-
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
-
Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study
Bizjak, M., Košnik, M., Dinevski, D., et al. Allergy. First published: 04 December 2021
-
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study
Maurer, M, Giménez-Arnau, A, Bernstein, JA, et al. Allergy. First published: 13 November 2021
-
Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis
Luo, L, Luo, Y, Xu, J, et al. Allergy. First published: 05 November 2021
-
Impaired skin barrier and allergic sensitization in early infancy
Wärnberg Gerdin, S, Lie, A, Asarnoj, A, et al. Allergy. First published: 05 November 2021
-
Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies
Andersson, A.M., Sølberg, J., Koch, A., et al. Allergy. First published: 25 October 2021
-
Transcriptome-based identification of novel endotypes in adult atopic dermatitis
Lefèvre-Utile, A., Saichi, M., Oláh, P., et al. Allergy. First published: 24 October 2021
-
The benefit of late readings in patch testing depends both on allergen and patient characteristics
Forkel, S., Schubert, S., Dickel, H., et al. Allergy. First published: 23 October 2021
-
Specific T cells targeting Staphylococcus aureus Fibronectin-binding protein 1 induce a type 2/type 1 inflammatory response in sensitized atopic dermatitis patients
Farag, A.K., Roesner, L.M., Wieschowski, S., et al. Allergy. First published: 03 October 2021
-
Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients
Guttman-Yassky, E, Renert-Yuval, Y, Bares, J, et al. Allergy. First published: 30 August 2021
-
Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood
Schoos, A-MM, Chawes, BL, Bønnelykke, K, Stokholm, J, Rasmussen, MA, Bisgaard, H. Allergy. First published: 24 September 2021
-
Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-/histamine-mediated angioedema
Bindke, G., Gehring, M., Wieczorek, D., Kapp, A., Buhl, T. and Wedi, B. Allergy. First published: 20 July 2021
-
Long-term prevention of hereditary angioedema attacks with lanadelumab: the HELP OLE Study
Banerji, A., Bernstein, J.A., Johnston, D.T., et al. Allergy. First published: 21 July 2021
-
Environment-dependent alterations of immune mediators in urban and rural south African children with atopic dermatitis
Lunjani, N, Tan, G, Dreher, A, et al. Allergy. 2022; 77: 569– 581
-
MR1-dependent immune surveillance of the skin contributes to pathogenesis and is a photobiological target of UV light therapy in a mouse model of atopic dermatitis.
Naidoo, K., Woods, K., Pellefigues, C., et al. Allergy. 2021; 76: 3155-3170
-
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V., Dreyer, S., Zeitvogel, J., et al. Allergy. 2021; 76: 3145-3154
-
Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study
Kocatürk, E, Al-Ahmad, M, Krause, K, et al. Allergy. 2021; 76: 3133-3144
-
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L., Herberth, G., Seiwert, B., et al. Allergy. 2021; 76: 3122-3132
-
Vascular inflammation in moderate-to-severe atopic dermatitis is associated with enhanced Th2 response
Villani, A.P., Pavel, A.B., Wu, J., et al. Allergy. 2021; 76: 3107-3121
-
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
-
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis
Czarnowicki, T., Kim, H.J., Villani, et al. Allergy. 2021; 76: 3080-3093
-
Electrical impedance spectroscopy for the characterization of skin barrier in atopic dermatitis
Rinaldi, A.O., Korsfeldt, A., Ward, S. et al. Allergy. 2021; 76: 3066-3079
-
An integrated scalp and blood biomarker approach suggeststhe systemic nature of alopecia areata
Glickman, J.W., Dubin, C., Dahabreh, D., et al. Allergy. 2021; 76: 3053-3065
-
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiency
Eyice Karabacak, D., Demir, S., Yeğit, O.O., et al. Allergy.2021; 76: 2535-2543
-
Association between ambient air pollution and development and persistence of atopic and non-atopic eczema in a cohort of adults
Lopez, D.J., Lodge, C.J., Bui, D.S., et al. Allergy.2021; 76: 2524-2534
-
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum
Bin, L., Malley, C., Taylor, P., et al. Allergy.2021; 76: 2510-2523
-
Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis
Hou, T., Tsang, M.S.-M., Chu, et al. Allergy.2021; 76: 2102-2114
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
Chiricozzi, A., Talamonti, M., De Simone, C., et al. Allergy. 2021; 76: 1813-1824
-
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial
Ohsawa, I., Honda, D., Suzuki, Y., Allergy.2021; 76: 1789-1799
-
https://onlinelibrary.wiley.com/doi/10.1111/all.14692
Fatty acid-binding protein 3 controls contact hypersensitivity through regulating skin dermal Vγ4+ γ/δ T cell in a murine model
Kobayashi, S, Phung, HT, Kagawa, Y, et al. et al. Allergy. 2021; 76: 1776.1788
-
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study
Lumry, W.R., Weller, K., Magerl, M., et al. Allergy.2021; 76: 1188-1198
-
Microbial and transcriptional differences elucidate atopic dermatitis heterogeneity across skin sites
Ottman, N, Barrientos-Somarribas, M, Fyhrquist, N, et al. Allergy. 2021; 76: 1173– 1187
-
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Lauffer, F, Baghin, V, Standl, M, et al. Allergy. 2021; 76: 1158– 1172
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
Kocatürk, E, Salman, A, Cherrez-Ojeda, I, et al. Allergy. 2021; 76: 816– 830
-
Integrative transcriptome analysis deciphers mechanisms of nickel contact dermatitis
Wisgrill, L, Werner, P, Jalonen, E, et al. Allergy. 2021; 76: 804– 815
-
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin
Pavel A. B., Renert- Yuval, Y., Wu, J., et al. Allergy. 2021; 76: 314- 325
-
Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort
Gonzalez T., Stevens, M. L., Baatyrbek Kyzy, A., et al. Allergy. 2021; 76:302- 313
-
Inhibition of mite-induced dermatitis, pruritus, and nerve sprouting in mice by the endothelin receptor antagonist bosentan
Kido-Nakahara M., Wang, B., Ohno, F., et al. Allergy. 2021; 76: 291- 301
-
Dysregulated skin barrier function in Tmem79 mutant mice promotes IL-17A-dependent spontaneous skin and lung inflammation
Saunders, SP, Floudas, A, Moran, T, et al. Allergy. 2020; 75: 3216– 3227
-
IgM and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria
Altrichter, S, Zampeli, V, Ellrich, A, Zhang, K, Church, MK, Maurer, M. Allergy. 2020; 75: 3208– 3215
-
Skin pH–dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity
Hülpüsch, C, Tremmel, K, Hammel, G, et al. Allergy. 2020; 75: 2888– 2898
-
Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks
Riedl, MA, Maurer, M, Bernstein, JA, et al. Allergy. 2020; 75: 2879– 2887
-
Skin-infiltrating basophils promote atopic dermatitis-like inflammation via IL-4 production in mice
Yamanishi, Y, Mogi, K, Takahashi, K, Miyake, K, Yoshikawa, S, Karasuyama, H. Allergy. 2020; 75: 2613– 2622
-
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
-
Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice
Hirata, S-I, Nagatake, T, Sawane, K, et al. Allergy. 2020; 75: 1939– 1955
-
Comel-Netherton syndrome: A local skin barrier defect in the absence of an underlying systemic immunodeficiency
Stuvel, K, Heeringa, JJ, Dalm, VASH, et al. Allergy. 2020; 75: 1710– 1720
-
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor
Bova, M, Suffritti, C, Bafunno, V, et al. Allergy. 2020; 75: 1394– 1403
-
Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema
Weller, K, Donoso, T, Magerl, M, et al. Allergy. 2020; 75: 1165– 1177
-
Interleukin 31 in insect bite hypersensitivity-Alleviating clinical symptoms by active vaccination against itch
Olomski, F, Fettelschoss, V, Jonsdottir, S, et al. Allergy. 2020; 75: 862– 871
-
Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis
Fricke, J, Ávila, G, Keller, T, et al. Allergy. 2020; 75: 423– 432
-
Exonic mutations associated with atopic dermatitis disrupt lympho-epithelial kazal-type related inhibitor action and enhance its degradation
Ramesh, K, Matta, SA, Chew, FT, Mok, YK. Allergy. 2020; 75: 403– 411
-
Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial
Plummer, EL, Chebar Lozinsky, A, Tobin, JM, et al. Allergy. 2020; 75: 127– 136
-
Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Ariëns, LFM, van der Schaft, J, Bakker, DS, et al. Allergy. 2020; 75: 116– 126
-
Markers of microbial exposure lower the incidence of atopic dermatitis
Chatenoud, L, Bertuccio, P, Turati, F, et al. Allergy. 2020; 75: 104– 115
-
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
Schoepke, N, Asero, R, Ellrich, A, et al. Allergy. 2019; 74: 2427– 2436
-
miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation
Vaher, H, Runnel, T, Urgard, E, et al. Allergy. 2019; 74: 2146– 2156
-
Direct assessment of skin epithelial barrier by electrical impedance spectroscopy
Rinaldi, AO, Morita, H, Wawrzyniak, P, et al. Allergy. 2019; 74: 1934– 1944
-
Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β
Schwartz, C, Moran, T, Saunders, SP, et al. Allergy. 2019; 74: 1920– 1933
-
Langerhans cells mediate the skin-induced tolerance to ovalbumin via Langerin in a murine model
Luo, Y, Wang, S, Liu, X, Wen, H, Li, W, Yao, X. Allergy. 2019; 74: 1738– 1747
-
Pruritus in ordinary scabies: IL-31 from macrophages induced by overexpression of thymic stromal lymphopoietin and periostin
Hashimoto, T, Satoh, T, Yokozeki, H. Allergy. 2019; 74: 1727– 1737
-
Transient epidermal barrier deficiency and lowered allergic threshold in filaggrin‐hornerin (FlgHrnr−/−) double‐deficient mice
Rahrig, S, Dettmann, JM, Brauns, B, et al. Allergy. 2019; 74: 1327– 1339
-
Eicosanoid mediator profiles in different phenotypes of nonsteroidal anti-inflammatory drug-induced urticaria
Doña, I, Jurado-Escobar, R, Perkins, JR, et al. Allergy. 2019; 74: 1135– 1144